Drug induced interstitial lung disease: a systematic review
S. Skeoch (Manchester, United Kingdom), N. Weatherley (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), A. Oldroyd (Manchester, United Kingdom), C. Johns (Sheffield, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Giollo (Leeds, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Waterton (Manchester, United Kingdom), M. Buch (Leeds, United Kingdom), K. Linton (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), B. Stephen (Sheffield, United Kingdom), N. Chaudhuri (Manchester, United Kingdom)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Skeoch (Manchester, United Kingdom), N. Weatherley (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), A. Oldroyd (Manchester, United Kingdom), C. Johns (Sheffield, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Giollo (Leeds, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Waterton (Manchester, United Kingdom), M. Buch (Leeds, United Kingdom), K. Linton (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), B. Stephen (Sheffield, United Kingdom), N. Chaudhuri (Manchester, United Kingdom). Drug induced interstitial lung disease: a systematic review. 2244
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: